In vitro activity of tebipenem, a new oral carbapenem antibiotic, against β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae

Kozue Kishii, Naoko Chiba, Miyuki Morozumi, Akiko Ono, Takashi Ida, Kimiko Ubukata

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In vitro activity of tebipenem, a new oral carbapenem antibiotic, against clinical Haemophilus influenzae isolates was compared with those of 8 reference agents. Isolates were classified into 6 resistance classes after PCR identification of β-lactamase genes and ftsI gene mutations. For all isolates, the minimal concentration at which 90% of isolates were inhibited was lower for tebipenem than for the reference oral antibiotics, except for cefditoren. Tebipenem also showed excellent bactericidal activity against β-lactamase-nonproducing, ampicillin-resistant isolates.

Original languageEnglish
Pages (from-to)3970-3973
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume54
Issue number9
DOIs
Publication statusPublished - 2010 Sep 1

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro activity of tebipenem, a new oral carbapenem antibiotic, against β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae'. Together they form a unique fingerprint.

  • Cite this